Quote | Spruce Biosciences Inc. (NASDAQ:SPRB)
Last: | $0.70 |
---|---|
Change Percent: | -1.28% |
Open: | $0.71 |
Close: | $0.70 |
High: | $0.710101 |
Low: | $0.6977 |
Volume: | 194,704 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Spruce Biosciences Inc. (NASDAQ:SPRB)
Presentation to highlight baseline characteristics of Spruce’s CAHmelia program evaluating tildacerfont in adult congenital adrenal hyperplasia (CAH), as an illustration of outcomes of current pediatric CAH disease management Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-s...
2024-03-14 17:15:01 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for SPRB on March 14, 2024 04:15PM ET. The previous analyst recommendation was Market Outperform. SPRB was trading at $0.8106 at issue of the analyst recommendation. The overall analyst...
Message Board Posts | Spruce Biosciences Inc. (NASDAQ:SPRB)
Subject | By | Source | When |
---|---|---|---|
$SPRB MomentumIts gaining last trade up | pzottkpz | investorshub | 05/14/2023 3:01:39 AM |
$SPRB MomentumIts trading | TheFinalCD | investorshub | 05/14/2023 12:32:56 AM |
$SPRB Anyone hear anything lately? Want to see this one go | MiamiGent | investorshub | 05/11/2023 8:49:01 AM |
$SPRB Do we have a winner?Turn around time? | MiamiGent | investorshub | 05/10/2023 11:39:50 PM |
news out | pzottkpz | investorshub | 05/07/2023 8:29:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Presentation to highlight baseline characteristics of Spruce’s CAHmelia program evaluating tildacerfont in adult congenital adrenal hyperplasia (CAH), as an illustration of outcomes of current pediatric CAH disease management Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-s...
Spruce Biosciences Inc (NASDAQ:SPRB) shares plummeted on Thursday after the company released topline results from its CAHmelia-203 Phase 2b st...
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to...